FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385166006: gel vaginal (forme pharmaceutique)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479429018 Vaginal gel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3537293019 Conventional release vaginal gel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3537294013 Conventional release vaginal gel (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
616981000241119 gel vaginal (forme pharmaceutique) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
9551000188110 gel vaginal fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vaginal gel est un(e) (attribut) forme pharmaceutique pour usage vaginal (forme pharmaceutique) true Inferred relationship Some
Vaginal gel est un(e) (attribut) Gel false Inferred relationship Some
Vaginal gel Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Vaginal gel Has dose form intended site (attribute) Vaginal true Inferred relationship Some
Vaginal gel Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Vaginal gel Has basic dose form (attribute) Gel true Inferred relationship Some
Vaginal gel Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Iodine (as povidone iodine) 100 mg/g vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Povidone-iodine 10% vaginal gel (product) a une forme pharmaceutique (attribut) False Vaginal gel Inferred relationship Some
Metronidazole 7.5 mg/g vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Acetic acid 9.2 mg/g vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Dinoprostone 400 microgram/mL vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Progesterone 40 mg/g vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Progesterone 80 mg/g vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some
Nonoxynol 20 mg/mL vaginal gel a une forme pharmaceutique (attribut) True Vaginal gel Inferred relationship Some

This concept is not in any reference sets

Back to Start